Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

681.00p
   
  • Change Today:
      18.00p
  • 52 Week High: 697.00p
  • 52 Week Low: 232.50p
  • Currency: UK Pounds
  • Shares Issued: 120.75m
  • Volume: 170,800
  • Market Cap: £822.33m
  • RiskGrade: 125
  • Beta: 1.79

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
07-Oct-25 Canaccord Genuity Buy 626.00p - 451.00p Reiteration
26-Aug-25 RBC Capital Markets Outperform 556.00p 800.00p 930.00p Reiteration
01-Aug-25 Peel Hunt Limited Buy 464.50p - 451.00p Reiteration
15-Jul-25 JP Morgan Cazenove Neutral 362.50p 490.00p 400.00p Reiteration
24-Sep-24 Deutsche Hold 377.00p 250.00p 380.00p Reiteration
20-Mar-24 Numis Hold 186.60p - 180.00p Reiteration
26-Sep-23 Liberum Capital Hold 291.50p 350.00p 310.00p Reiteration
13-Jul-17 Shore Capital Not Rated 8.85p - - Reiteration
06-Jul-17 N 1 Singer Hold 9.89p - 7.80p Reiteration
21-Oct-16 Jefferies Buy 3.16p - 8.00p Reiteration
18-Jun-14 Oriel Securities Add - - - Reiteration
10-Apr-14 Nplus1 Brewin Hold - 3.30p 3.30p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

OXB Market Data

Currency UK Pounds
Share Price 681.00p
Change Today 18.00p
% Change 2.71 %
52 Week High 697.00p
52 Week Low 232.50p
Volume 170,800
Shares Issued 120.75m
Market Cap £822.33m
Beta 1.79
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average
17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average
Price Trend
84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average
86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average
Income Not Available
Growth
5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average
24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 3
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 06-Jan-2026

Time Volume / Share Price
13:23 2 @ 684.03p
13:18 31 @ 681.00p
13:18 242 @ 682.00p
13:18 109 @ 682.00p
13:18 271 @ 683.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page